Journal of Korean Critical Care Nursing (중환자간호학회지)

Korean Society of Critical Care Nursing (한국중환자간호학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Clinical Outcomes between Rebound Hyperthermia and Non-Rebound Hypertherma Groups in Postcardiac Arrest Syndrome Patients Undergoing Targeted Temperature Management

목표체온유지치료를 적용한 심정지 후 증후군 환자에서 반동성 고체온 발생군과 비발생군의 임상결과 비교

  • Received : 2023.06.28
  • Accepted : 2023.10.20
  • Published : 2023.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : This retrospective study aims to provide basic data for intervention to improve clinical outcomes and identify the characteristics of the rebound hyperthermia (RHG) and non-rebound hyperthermia (NRHG) groups by checking body temperature in patients with post-cardiac arrest syndrome. Method : The study involved 118 patients who completed target temperature management (TTM) in an acute-care unit. Data were analyzed for frequency, percentages, mean, standard deviation, median, and quartiles, and compared using the chi-squared test and Mann-Whitney U-test. Results : Rebound hyperthermia (RH) was observed in 74 (62.7%) patients, predominantly male (69.5%), with an average age of 64.54 ± 15.98, and a body mass index of 23.22 ± 4.75kg/m2 (overweight). Hypertension (50%) was the most common co-morbidity, followed by diabetes and heart disease (33.1%). Neuron-specific enolase levels were higher in the NRHG 24, 48, and 72 hours after recovery of spontaneous circulation (p = .037, p < .001, p = .008). The APHCHE IV was also higher in the NRHG (p < .001). RH occurred 25.49 (7.28-52.96) hours after TTM completion, lasting for 2 (1-3) hours. Temperature reduction strategies included notifying doctors, administering antipyretics, and nursing intervention, with the latter being the most common at 94.6%. Half of the subjects in the RHG and 77.3% in the NRHG fell into cerebral performance categories 3, 4, and 5 (p = .003). Conclusion : RH is more likely a body mechanism related to CPR and TTM than a result of pathogenic infection. Therefore, we require an active intervention for hyperthermia, and a patient-specific nursing intervention protocol.

Keywords

References

  1. Kim YM, Jeung KW, Kim WY, Park YS, Oh JS, You YH, et al. 2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 5. Post-cardiac arrest care. Clinical and Experimental Emergency Medicine. 2021;8(S):S41-S64. https://doi.org/10.15441/ceem.21.025
  2. Jeon SB. Targeted Temperature Management at 36℃ after In-Hospital Cardiac Arrest Trial (TTM-36 IHCA Trial): Study Protocol for an Investigator-Initiated, Single-Center, Randomized, Controlled, Assessor-Blinded, Pilot Clinical Trial. Journal of Neurocritical Care. 2016;9(1):7-15. https://doi.org/10.18700/jnc.2016.9.1.7
  3. Natarajan G, Laptook A, Shankaran S. Therapeutic Hypothermia: How Can We Optimize This Therapy to Further Improve Outcomes? Clinical Perinatol. 2018;45(2):241-55. https://doi.org/10.1016/j.clp.2018.01.010
  4. Blennow Nordstrom E, Lilja G, Vestberg S, Ullen S, Friberg H, Nielsen N, et al. Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). Biomedcentral Cardiovascular Disorders. 2020;20(1):439. https://doi.org/10.1186/s12872-020-01721-9
  5. Jahandiez V, Cour M, Abrial M, Loufouat J, Ovize M, Argaud L. Therapeutic Hypothermia After Cardiac Arrest: Involvement of the Risk Pathway in Mitochondrial PTP-Mediated Neuroprotection. Shock. 2019;52(2):224-9. https://doi.org/10.1097/SHK.0000000000001234
  6. Kang Y. Management of post-cardiac arrest syndrome. Acute Critical Care. 2019;34(3):173-8. https://doi.org/10.4266/acc.2019.00654
  7. Borgquist O, Wise MP, Nielsen N, Al-Subaie N, Cranshaw J, Cronberg T, et al. Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33 degrees C and 36 degrees C. Critical Care Medicine. 2017;45(8):1337-43. https://doi.org/10.1097/CCM.0000000000002367
  8. Armahizer MJ, Strein M, Pajoumand M. Control of Shivering During Targeted Temperature Management. Critical Care Nursing Quarterly. 2020;43 (2):251-66. https://doi.org/10.1097/CNQ.0000000000000305
  9. Akin M, Garcheva V, Sieweke JT, Adel J, Flierl U, Bauersachs J, et al. Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia-experience from the HAnnover COoling REgistry (HACORE). Public Library of Science One. 2021;16(1):e0245210. https://doi.org/10.1371/journal.pone.0245210
  10. Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VR, Deakin CD, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation. 2015;95:202-22. https://doi.org/10.1016/j.resuscitation.2015.07.018
  11. Makker P, Kanei Y, Misra D. Clinical Effect of Rebound Hyperthermia After Cooling Postcardiac Arrest: A Meta-Analysis. Therapeutic Hypothermia Temparature Management. 2017;7(4):206-9. https://doi.org/10.1089/ther.2017.0009
  12. Holm A, Kirkegaard H, Taccone FS, Soreide E, Grejs AM, Toome V, et al. Factors Associated With Rebound Hyperthermia After Targeted Temperature Management in Out-of-Hospital Cardiac Arrest Patients: An Explorative Substudy of the Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors Trial. Critical Care Explorations. 2021;3(7):e0458. https://doi.org/10.1097/CCE.0000000000000458
  13. Leary M, Grossestreuer AV, Iannacone S, Gonzalez M, Shofer FS, Povey C, et al. Pyrexia and neurologic outcomes after therapeutic hypothermia for cardiac arrest. Resuscitation. 2013;84(8):1056-61. https://doi.org/10.1016/j.resuscitation.2012.11.003
  14. Department of internal medicine, Seoul National University college. SNUH manual of medicine. 2019.
  15. Grossestreuer AV, Abella BS, Sheak KR, Cinousis MJ, Perman SM, Leary M, et al. Inter-rater reliability of post-arrest cerebral performance category (CPC) scores. Resuscitation. 2016;109:21-4. https://doi.org/10.1016/j.resuscitation.2016.09.006
  16. Cocchi MN, Boone MD, Giberson B, Giberson T, Farrell E, Salciccioli JD, et al. Fever after rewarming: incidence of pyrexia in postcardiac arrest patients who have undergone mild therapeutic hypothermia. Journal of Intensive Care Medicine. 2014;29(6):365-9. https://doi.org/10.1177/0885066613491932
  17. Peluso L, Abella BS, Ferrer R, Kucher N, Sunde K, Taccone FS. Fever management in COVID-19 patients. Minerva Anestesiol. 2021;87(1):1-3. https://doi.org/10.23736/S0375-9393.20.15195-2
  18. Shin YS, Kim SR, Yoo SH, Kim SH, Kim JH, Kim HJ, et al. Development and Evaluation of an Evidence-Based Nursing Protocol for Fever Management in Adult Patients. Korean Journal of Adult Nursing. 2013;25(3):250-62. https://doi.org/10.7475/kjan.2013.25.3.250
  19. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology. 2018;9:754. https://doi.org/10.3389/fimmu.2018.00754
  20. Vondrakova D, Kruger A, Janotka M, Malek F, Dudkova V, Neuzil P, et al. Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection. Critical Care. 2017;21(1):172. https://doi.org/10.1186/s13054-2017-1766-2
  21. Moon S, Ryoo H, Ahn J, Lee D, Shin S, Park J. Association of response time interval with neurological outcomes after out-of-hospital cardiac arrest according to bystander CPR. The American Journal of Emergency Medicine. 2020;38(9):1760-6. https://doi.org/10.1016/j.ajem.2020.05.108